Pages that link to "Q40514786"

The following pages link to Interactions of dopamine D1 and D2 receptor antagonists with D-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions. (Q40514786):

Displaying 30 items.

• Methamphetamine-induced toxicity: an updated review on issues related to hyperthermia (Q23919891) (← links)
• Methamphetamine toxicity and messengers of death (Q24647617) (← links)
• Methamphetamine treatment during development attenuates the dopaminergic deficits caused by subsequent high‐dose methamphetamine administration (Q30443801) (← links)
• Meth math: modeling temperature responses to methamphetamine. (Q33704837) (← links)
• Dopamine D(3) receptors contribute to methamphetamine-induced alterations in dopaminergic neuronal function: role of hyperthermia (Q33768609) (← links)
• Selective vulnerability in striosomes and in the nigrostriatal dopaminergic pathway after methamphetamine administration : early loss of TH in striosomes after methamphetamine. (Q33873281) (← links)
• Methamphetamine-induced dopamine transporter complex formation and dopaminergic deficits: the role of D2 receptor activation (Q34214699) (← links)
• Comparison of ( )‐methamphetamine, ±‐Methylenedioxymethamphetamine, ( )‐amphetamine and ±‐fenfluramine in rats on egocentric learning in the Cincinnati water maze (Q34367678) (← links)
• Effects of ( /-)3,4-methylenedioxymethamphetamine, ( /-)3,4-methylenedioxyamphetamine and methamphetamine on temperature and activity in rhesus macaques (Q34552306) (← links)
• Modification of Monoaminergic Activity by MAO Inhibitors Influences Methamphetamine Actions (Q35161736) (← links)
• A role for D1 dopamine receptors in striatal methamphetamine-induced neurotoxicity (Q35221735) (← links)
• Mechanisms of methamphetamine-induced dopaminergic neurotoxicity (Q35863901) (← links)
• Electroencephalographic and convulsive effects of binge doses of ( )-methamphetamine, 5-methoxydiisopropyltryptamine, and (±)-3,4-methylenedioxymethamphetamine in rats. (Q35618891) (← links)
• D1 and D2 antagonists reverse the effects of appetite suppressants on weight loss, food intake, locomotion, and rebalance spiking inhibition in the rat NAc shell (Q35871393) (← links)
• Do preclinical findings of methamphetamine-induced motor abnormalities translate to an observable clinical phenotype? (Q36241219) (← links)
• Methamphetamine alters vesicular monoamine transporter-2 function and potassium-stimulated dopamine release (Q36537905) (← links)
• Differential regional effects of methamphetamine on dopamine transport (Q36968822) (← links)
• Sigma (σ) receptor ligand, AC927 (N-phenethylpiperidine oxalate), attenuates methamphetamine-induced hyperthermia and serotonin damage in mice (Q37052863) (← links)
• Mechanisms underlying methamphetamine-induced dopamine transporter complex formation (Q37162131) (← links)
• Monoamine transporter as a target molecule for psychostimulants (Q37553146) (← links)
• The role of dopamine receptors in the neurotoxicity of methamphetamine. (Q38100197) (← links)
• Neurobehavioral Effects from Developmental Methamphetamine Exposure (Q38621196) (← links)
• Methamphetamine and core temperature in the rat: ambient temperature, dose, and the effect of a D2 receptor blocker (Q40245565) (← links)
• Lipopolysaccharide mitagates methamphetamine-induced striatal dopamine depletion via modulating local TNF-alpha and dopamine transporter expression (Q40395351) (← links)
• Pharmacological and behavioral determinants of cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine, and para-methoxyamphetamine-induced hyperthermia. (Q40448953) (← links)
• In hamsters the D1 receptor antagonist SCH23390 depresses ventilation during hypoxia (Q41930844) (← links)
• Striatal dopamine D1 and D2 receptors: widespread influences on methamphetamine-induced dopamine and serotonin neurotoxicity. (Q46807459) (← links)
• Trace amine-associated receptor 1 regulation of methamphetamine-induced neurotoxicity. (Q47788814) (← links)
• Expression of dopamine transporter in the different cerebral regions of methamphetamine-dependent rats (Q48413341) (← links)
• Brain Renin-Angiotensin System Blockade Attenuates Methamphetamine-Induced Hyperlocomotion and Neurotoxicity (Q49721288) (← links)